MF
Matthew Foster
Chief Restructuring OfficerMatthew Foster is Chief Restructuring Officer of Syros Pharmaceuticals, Inc. from March 1, 2025.
Positions
- Company NameSyros Pharmaceuticals, Inc.Stock CodeSYRSPositionChief Restructuring OfficerColleagues
- JEJames E. BradnerFounder
- NSNathanael S. GrayScientific Founder & Member of Scientific Advisory Board
- BEBradley E. BernsteinMember of Scientific Advisory Board
- SAScott A. BillerMember of Scientific Advisory Board
- GEGerard EvanMember of Scientific Advisory Board
- SKStefan KnappMember of Scientific Advisory Board
